A focused review on the use of botulinum toxins for neuropathic pain

被引:99
作者
Argoff, CE [1 ]
机构
[1] NYU, Sch Med, N Shore Univ Hosp, Cohn Pain Management Ctr, Bethpage, NY 11714 USA
关键词
neuropathic pain; nociceptive pain; botulinum toxins; analgesics;
D O I
10.1097/00002508-200211001-00010
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Understanding the pathophysiology of a pain syndrome is helpful in selecting appropriate treatment strategies. Nociceptive pain is related to damage to tissues due to thermal, chemical, mechanical, or other types of irritants. Neuropathic pain results from injury to the peripheral or central nervous system. Common examples of neuropathic pain include postherpetic neuralgia, diabetic neuropathy, complex regional pain syndrome, and pain associated with spinal cord injuries. Nociceptive pain may have similar clinical characteristics to neuropathic pain. It is also possible for acute nociceptive pain to become neuropathic in nature, as with myofascial pain syndrome. A clear benefit of botulinum toxin therapy for treatment of neuropathic pain disorders is that it often relieves pain symptoms. Although the precise mechanism of pain relief is not completely understood, the injection of botulinum toxin may reduce various substances that sensitize nociceptors. As a result, botulinum toxin types A and B are now being actively studied in nociceptive and neuropathic pain disorders to better define their roles as analgesics.
引用
收藏
页码:S177 / S181
页数:5
相关论文
共 22 条
[1]   Uninjured C-fiber nociceptors develop spontaneous activity and α-adrenergic sensitivity following L6 spinal nerve ligation in monkey [J].
Ali, Z ;
Ringkamp, M ;
Hartke, TV ;
Chien, HF ;
Flavahan, NA ;
Campbell, JN ;
Meyer, RA .
JOURNAL OF NEUROPHYSIOLOGY, 1999, 81 (02) :455-466
[2]   Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain [J].
Ali, Z ;
Raja, SN ;
Wesselmann, U ;
Fuchs, PN ;
Meyer, RA ;
Campbell, JN .
PAIN, 2000, 88 (02) :161-168
[3]   Epidemiology of complex regional pain syndrome: a retrospective chart review of 134 patients [J].
Allen, G ;
Galer, BS ;
Schwartz, L .
PAIN, 1999, 80 (03) :539-544
[4]  
[Anonymous], 1999, Travell Simons' Myofascial Pain and Dysfunction: The Trigger Point Manual
[5]  
ARGOFF CE, 1999, WORLD PAIN C IASP M
[6]  
Bennett G.J., 1998, HOSP PRACT, V33, P95
[7]  
Bennett GJ, 2000, J PAIN SYMPTOM MANAG, V19, pS2
[8]   Deconstructing migraine headache into peripheral and central sensitization [J].
Burstein, R .
PAIN, 2001, 89 (2-3) :107-110
[9]   Pain: Molecular mechanisms [J].
Costigan, M ;
Woolf, CJ .
JOURNAL OF PAIN, 2000, 1 (03) :35-44
[10]  
Cui M, 2000, SOC NEUR ABST, V26, P656